The Current Ratio as of January 2026 (TTM) for Poniard Pharmaceuticals, Inc. (PARD) is 3.23

According to Poniard Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.23. This represents a change of 20.11% compared to the average of 2.69 of the last 4 quarters.

Poniard Pharmaceuticals, Inc. (PARD) Historical Current Ratio (quarterly & annually)

How has PARD Current Ratio performed in the past?

The mean historical Current Ratio of Poniard Pharmaceuticals, Inc. over the last ten years is 6.03. The current 3.23 Current Ratio has changed 5.26% with respect to the historical average. Over the past ten years (40 quarters), PARD's Current Ratio was at its highest in in the June 2006 quarter at 24.67. The Current Ratio was at its lowest in in the March 2006 quarter at 0.57.

Poniard Pharmaceuticals, Inc. (PARD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Poniard Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Poniard Pharmaceuticals, Inc. (PARD) Average Current Ratio

How has PARD Current Ratio performed in the past?

The current Current Ratio of Poniard Pharmaceuticals, Inc. (PARD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Poniard Pharmaceuticals, Inc. (PARD) Current Ratio vs. Peers

How is PARD’s Current Ratio compared to its peers?

Poniard Pharmaceuticals, Inc.’s Current Ratio is greater than VioQuest Pharmaceuticals, Inc. (0.22), greater than Regenicin, Inc. (0.00), greater than Q BioMed Inc. (0.01), greater than Scopus BioPharma Inc. (0.05), less than Strategic Partners A/S (3.81), greater than RenovaCare, Inc. (2.59), greater than Vaxxinity, Inc. (1.89), greater than PaxMedica, Inc. Common Stock (3.16), greater than NovAccess Global Inc. (0.01), less than Aeolus Pharmaceuticals, Inc. (4.25),

Build a custom stock screener for Poniard Pharmaceuticals, Inc. (PARD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poniard Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Poniard Pharmaceuticals, Inc. (PARD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Poniard Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.